
Results
7
Stocks with a market cap under US$50M.
7 companies
Sprint Bioscience
Market Cap: SEK 401.0m
A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.
SPRINT
SEK 3.80
7D
-6.4%
1Y
630.8%
Elicera Therapeutics
Market Cap: SEK 185.5m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 2.83
7D
-0.9%
1Y
-47.4%
Ascelia Pharma
Market Cap: SEK 86.5m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 0.67
7D
-79.5%
1Y
-84.3%
Subgen AI
Market Cap: SEK 59.5m
Develops artificial intelligence-based models and applications to control data for government and businesses.
SUBGEN
SEK 0.06
7D
-14.0%
1Y
n/a
ODI Pharma
Market Cap: SEK 40.3m
A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.
ODI
SEK 2.16
7D
-15.6%
1Y
35.0%
Chosa Oncology
Market Cap: SEK 34.4m
Develops oncology drugs cisplatin for the treatment of cancer.
CHOSA
SEK 0.53
7D
0%
1Y
-59.2%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%